Question 1

What are the current odds for When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema??

Accepted Answer

As of March 26, 2026, the Kalshi odds for When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema? are: Before 2028: 65%, Before October 2027: 45%, Before July 2027: 20%. These probabilities are derived from real-money trading and update in real time.

Question 2

Where can I bet on When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema??

Accepted Answer

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema? is currently available on Kalshi. Check PredictMarketCap for cross-platform availability as new markets are added regularly.

Question 3

How are When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema? prediction market odds calculated?

Accepted Answer

Prediction market odds reflect the aggregate opinion of traders who risk real money on outcomes. The price of a share (e.g., 65¢) represents the market's implied probability (65%). Prices move as traders buy and sell based on new information, polls, and analysis.

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?

All Outcomes

Before 2028

Before October 2027

Frequently Asked Questions

Before July 2027